Hypoxemia is the most common complication of emergency endotracheal intubation of children, with an incidence of up to 50%. In this randomized trial of children under 16 years, nasal high-flow oxygen ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to the Bonhawa High Flow Oxygen Therapy system for patients with respiratory ...
IRVINE, Calif.--(BUSINESS WIRE)--Telesair, Inc., an innovator of next-generation respiratory care, and JPP Care, a leading Thai distributor of respiratory devices, jointly announced today that ...
IRVINE, Calif.--(BUSINESS WIRE)--Telesair, Inc., a technology leader in the respiratory industry, announced today that it has received FDA clearance to market its Bonhawa High Flow Oxygen Therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback